Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/8904_2014_363
Reference74 articles.
1. Al-Shamsi A, Hertecant JL, Al-Hamad S, Souid AK, Al-Jasmi F (2014) Mutation spectrum and birth prevalence of inborn errors of metabolism among Emiratis: a study from Tawam Hospital Metabolic Center, United Arab Emirates. Sultan Qaboos Univ Med J 14(1):e42–e49
2. Arranz JA, Pinol F, Kozak L et al (2002) Splicing mutations, mainly IVS6-1(G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients. Hum Mutat 20(3):180–188
3. Awata H, Endo F, Tanoue A, Kitano A, Nakano Y, Matsuda I (1994) Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I. Biochim Biophys Acta 1226(2):168–172
4. Barnby E (2014) Tyrosinemia type 1: an overview of nursing care. Pediatr Nursing 40(2):61–68
5. Bartlett DC, Lloyd C, McKiernan PJ, Newsome PN (2014) Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function. J Inherit Metab Dis 37(5):745–752.
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mutation spectrum of Tyrosinemia type I in Iran, A retrospective cohort study;European Journal of Medical Genetics;2024-10
2. Clinical, Biochemical, and Molecular Characteristics of Filipino Patients with Tyrosinemia Type 1;International Journal of Neonatal Screening;2024-08-31
3. Hereditary Tyrosinemia Type-1 With Late Presentation: A Case Report;Cureus;2024-06-23
4. Identification and Characterization of Novel Variants of Fumarylacetoacetate Hydrolase (FAH) Gene in Clinically Suspected Patients of Tyrosinemia Type 1: Tertiary Care Centre Study of North India;Indian Journal of Clinical Biochemistry;2024-06-05
5. Liver Disorders Caused by Inborn Errors of Metabolism;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3